Abstract

Reserpine 0.5-mg Capsules

Author(s): Allen Loyd V Jr

Issue: May/Jun 2013 - Volume 17, Number 3

Page(s): 237

Download in electronic PDF format for $75

Abstract

A formulation for preparing Reserpine 0.5-mg Capsules. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2013 Pg. 237	Reserpine 0.5-mg Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 310-312	Wetting and/or Solubilizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 380	Reserpine and Hydrochlorothiazide 0.125-mg/25-mg and 0.125-mg/50-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 101-105	Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Jul/Aug 2022 Pg. 270-274	A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline Author(s): Riepl Mike
May/Jun 2013 Pg. 233	Labetalol 50-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 515-518	Development and Evaluation of an Anti-aging Cosmetic Formulation Exploring Antioxidant Potential of Vitis vinifera L. Author(s): Carneiro Jaqueline, Marques Gonçalves Melissa, Vicente Pereira Airton
Sep/Oct 2001 Pg. 389-390	Capsule and Tablet Disintegrating Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 340-346	Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System Author(s): Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Jan/Feb 2003 Pg. 10-15 View Sample	Compounding for the Effects of Weapons of Mass Destruction Author(s): Sammarco Domenic A
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2013 Pg. 230	Estradiol 0.5-mg, 1-mg, or 2-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 236	Prednisone 10-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 496-500	Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Author(s): Goodwin Donald A, Fuhram L Clifton
Jul/Aug 1999 Pg. 291-294	The Basics of Compounding: Compounding Special Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 231	Ethambutol 400-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 232	Isoniazid 300-mg Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 342-346	Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets Author(s): Zaid Abdel Naser, Malkieh Numan, Kharoaf Maher, Ghoush Abeer Abu, Al-Ramahi Rowa'
Jan/Feb 2015 Pg. 60	Atenolol 25-, 50-, or 100-mg Capsules Author(s): Allen Loyd V Jr